Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 7—July 2020
Dispatch

Clinical Management of Argentine Hemorrhagic Fever using Ribavirin and Favipiravir, Belgium, 2020

Ioannis Veliziotis, Alain Roman, Delphine Martiny, Gerlind Schuldt, Marc Claus, Nicolas DaubyComments to Author , Sigi Van den Wijngaert, Charlotte Martin, Rakan Nasreddine, Claudia Perandones, Romain Mahieu, Corien Swaan, Serge Van Praet, Deborah Konopnicki, Maria A. Morales, Denis Malvy, Etienne Stevens, Philippe Dechamps, Erika Vlieghe, Olivier Vandenberg, Stephan Günther1, and Michèle Gérard1
Author affiliations: Université de Bruxelles, Brussels, Belgium (I. Veliziotis, A. Roman, D. Martiny, M. Claus, N. Dauby, S. Van den Wijngaert, C. Martin, R. Nasreddine, D. Konopnicki, E. Stevens, P. Dechamps, O. Vandenberg, M. Gérard); Saint-Pierre University Hospital, Brussels (I. Veliziotis, A, Roman, M. Claus, N. Dauby, C. Martin, R. Nasreddine, S. Van Praet, D. Konopnicki, E. Stevens, P. Deschamps, M. Gérard); Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany. (G. Schuldt, S. Günther); National Administration of Laboratories and Institutes of Health, Buenos Aires, Argentina (C. Perandones); Common Community Commission, Brussels (R. Mahieu); National Institute for Public Health and the Environment, Bilthoven, the Netherlands (C. Swaan); Instituto Nacional de Enfermedades Virales Humanas, Pergamino, Argentina (M.A. Morales); World Health Organization Collaborating Centre for Reference and Research of Arbovirus and Hemorrhagic Fever Virosis, Pergamino (M.A. Morales); University Hospital Center of Bordeaux, Bordeaux, France (D. Malvy); University Hospital Antwerp, Belgium (E. Vlieghe); University College London, London, UK (O. Vandenberg)

Main Article

Table 2

Contact with Junin virus for laboratory personnel, healthcare workers, and relatives for a patient with Argentine hemorrhagic fever, Belgium, 2020*

Contact, generic description
 High risk
 Low risk
No risk
Laboratory
Present in laboratory where patient's blood was processed X
Touching, moving closed blood tube X
Opening blood tube without touching sample X
Pipetting or other sample handling in biosafety cabinet with gloves X
Pipetting or other sample handling without gloves or not in biosafety cabinet X
Microscopy of wet sample or preparing thick smear outside biosafety cabinet X
Microscopy of dried or fixated sample outside biosafety cabinet X
Preparing smears, including thick smear in biosafety cabinet, with gloves X
Serologic test outside biosafety cabinet X
Discarding samples in waste bucket on floor X
Rinsing cell counting chambers and other reused materials
 X
Care giver
Brief presence in patient room, without touching anything X
Examining the patient and using gloves, mask, or glasses X
Examining the patient and not using gloves, mask, or glasses X
Drawing blood or handling other body fluids with gloves, mask, glasses X
Drawing blood or handling other body fluids without gloves, mask, or glasses X
Resuscitating patient and using gloves, mask, glasses X
Invasive procedure (catheter placement, puncture, lumbar puncture) with gloves, mask, glasses
X
General
Sexual contact X
Household contact with patient's body fluids X (Brussels, Belgium) X (Amsterdam, the Netherlands)
Having been near patient without contact with body fluids X

*High risk indicates unprotected contact (skin, mucosa) with body fluids or aerosols, not wearing intact PPE; low risk indicates protected contact with patient or body fluids, wearing intact and correct PPE; no risk indicates no contact with patient of body fluid. X indicates to which group the contact in the first column belongs. PPE, personal protective equipment.

Main Article

1These senior authors contributed equally to this article.

Page created: April 09, 2020
Page updated: June 18, 2020
Page reviewed: June 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external